title: Absorption and clearance of ceftazidime during CAPD.
authors.affiliation: Department of Renal Medicine, Royal Infirmary of Edinburgh Scotland, United Kingdom.
authors.forename: W D
authors.initials: WD
authors.lastname: Plant
authors.forename: U
authors.initials: U
authors.lastname: Martin
authors.forename: W
authors.initials: W
authors.lastname: Barron
authors.forename: P K
authors.initials: PK
authors.lastname: Scouse
authors.forename: R J
authors.initials: RJ
authors.lastname: Winney
authors.forename: L F
authors.initials: LF
authors.lastname: Prescott
mesh_terms: D000042:Absorption; D000328:Adult; D000368:Aged; D002442:Ceftazidime / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000493:pharmacokinetics*; D002511:Cephalosporins / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000493:pharmacokinetics*; D002851:Chromatography, High Pressure Liquid; D015314:Dialysis Solutions / Q000032:analysis; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory
chemical_list: D002511:Cephalosporins; D015314:Dialysis Solutions; D002442:Ceftazidime